Proposal to use pentoxifylline and Lyprinol therapy for chronic inflammatory diseases.
Ferreira
S H
SH
Departamento de Farmacologia, Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, SP, Brasil. shferrei@fmrp.usp.br
D002908:Chronic Disease; D004359:Drug Therapy, Combination; D006801:Humans; D007249:Inflammation / Q000188:drug therapy*; D008055:Lipids / Q000008:administration & dosage*; D010431:Pentoxifylline / Q000008:administration & dosage*; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
D008055:Lipids; D014409:Tumor Necrosis Factor-alpha; C418997:lyprinol; D010431:Pentoxifylline